BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22281300)

  • 1. Risk factors for molecular detection of adenovirus in pediatric hematopoietic stem cell transplantation recipients.
    Watson T; MacDonald D; Song X; Bromwich K; Campos J; Sande J; DeBiasi RL
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1227-34. PubMed ID: 22281300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.
    Yusuf U; Hale GA; Carr J; Gu Z; Benaim E; Woodard P; Kasow KA; Horwitz EM; Leung W; Srivastava DK; Handgretinger R; Hayden RT
    Transplantation; 2006 May; 81(10):1398-404. PubMed ID: 16732176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation.
    Myers GD; Bollard CM; Wu MF; Weiss H; Rooney CM; Heslop HE; Leen AM
    Bone Marrow Transplant; 2007 Jun; 39(11):677-86. PubMed ID: 17417664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome.
    Watcharananan SP; Kiertiburanakul S; Piyatuctsanawong W; Anurathapan U; Sungkanuparph S; Pakakasama S; Chantratita W; Hongeng S
    Pediatr Transplant; 2010 Aug; 14(5):675-81. PubMed ID: 20412509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematuria due to adenoviral infection in bone marrow transplant recipients.
    Bil-Lula I; Ussowicz M; Rybka B; Wendycz-Domalewska D; Ryczan R; Gorczyńska E; Kałwak K; Woźniak M
    Transplant Proc; 2010 Nov; 42(9):3729-34. PubMed ID: 21094847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
    Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
    Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.
    Sive JI; Thomson KJ; Morris EC; Ward KN; Peggs KS
    Clin Infect Dis; 2012 Nov; 55(10):1362-70. PubMed ID: 22903766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.
    Lee YJ; Chung D; Xiao K; Papadopoulos EB; Barker JN; Small TN; Giralt SA; Zheng J; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):387-92. PubMed ID: 23092814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients.
    Jeulin H; Salmon A; Bordigoni P; Venard V
    Clin Microbiol Infect; 2011 Nov; 17(11):1674-80. PubMed ID: 21481083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.
    Anderson EJ; Guzman-Cottrill JA; Kletzel M; Thormann K; Sullivan C; Zheng X; Katz BZ
    Pediatr Transplant; 2008 Mar; 12(2):219-27. PubMed ID: 18307672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation.
    Guérin-El Khourouj V; Dalle JH; Pédron B; Yakouben K; Bensoussan D; Cordeiro DJ; Peltier L; Ouachée-Chardin M; Baruchel A; Sterkers G
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):476-85. PubMed ID: 20869455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral infections in pediatric transplant recipients: a hospital-based study.
    de Mezerville MH; Tellier R; Richardson S; Hébert D; Doyle J; Allen U
    Pediatr Infect Dis J; 2006 Sep; 25(9):815-8. PubMed ID: 16940840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.
    Lee YJ; Huang YT; Kim SJ; Maloy M; Tamari R; Giralt SA; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):174-8. PubMed ID: 26318614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.
    Symeonidis N; Jakubowski A; Pierre-Louis S; Jaffe D; Pamer E; Sepkowitz K; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Jun; 9(2):108-13. PubMed ID: 17461995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.
    Lion T; Kosulin K; Landlinger C; Rauch M; Preuner S; Jugovic D; Pötschger U; Lawitschka A; Peters C; Fritsch G; Matthes-Martin S
    Leukemia; 2010 Apr; 24(4):706-14. PubMed ID: 20147979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival.
    Bruno B; Gooley T; Hackman RC; Davis C; Corey L; Boeckh M
    Biol Blood Marrow Transplant; 2003 May; 9(5):341-52. PubMed ID: 12766884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.
    Öhrmalm L; Lindblom A; Omar H; Norbeck O; Gustafson I; Lewensohn-Fuchs I; Johansson JE; Brune M; Ljungman P; Broliden K
    Bone Marrow Transplant; 2011 Feb; 46(2):267-72. PubMed ID: 20400984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program.
    Mynarek M; Ganzenmueller T; Mueller-Heine A; Mielke C; Gonnermann A; Beier R; Sauer M; Eiz-Vesper B; Kohstall U; Sykora KW; Heim A; Maecker-Kolhoff B
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):250-6. PubMed ID: 24269896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.